{"id":26525,"date":"2025-12-13T22:09:13","date_gmt":"2025-12-14T03:09:13","guid":{"rendered":"https:\/\/citystuff.com\/new-york\/2025\/12\/13\/johnson-johnson-agrees-to-40m-settlement-with-2-ovarian-cancer-patients-over-talcum-powder-use\/"},"modified":"2025-12-13T22:09:15","modified_gmt":"2025-12-14T03:09:15","slug":"johnson-johnson-agrees-to-40m-settlement-with-2-ovarian-cancer-patients-over-talcum-powder-use","status":"publish","type":"post","link":"https:\/\/citystuff.com\/new-york\/2025\/12\/13\/johnson-johnson-agrees-to-40m-settlement-with-2-ovarian-cancer-patients-over-talcum-powder-use\/","title":{"rendered":"Johnson & Johnson Agrees to $40M Settlement with 2 Ovarian Cancer Patients Over Talcum Powder Use"},"content":{"rendered":"

Introduction to Johnson & Johnson’s Talcum Powder Lawsuit<\/h2>\n

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer.
\nThe giant health care company said it would appeal the jury\u2019s liability verdict and compensatory damages.
\nThe verdict is the latest development in a longstanding legal battle over claims that talc in Johnson\u2019s Baby Powder and Shower to Shower body power was connected to ovarian cancer and mesothelioma, a cancer that strikes the lungs and other organs. Johnson & Johnson stopped selling powder made with talc worldwide in 2023.
\n<\/p>\n

Background of the Case<\/h2>\n

Johnson & Johnson said it would appeal the jury\u2019s liability verdict and compensatory damages.
\nIn October, another California jury ordered J&J to pay $966 million to the family of a woman who died of mesothelioma, claiming she developed the cancer because the baby powder she used was contaminated with the carcinogen asbestos.<\/p>\n

The Latest Case<\/h2>\n

In the latest case, the jury awarded $18 million to Monica Kent and $22 million to Deborah Schultz and her husband. \u201cThe only thing they did was be loyal to Johnson & Johnson as a customer for only 50 years,\u2019\u2019 said their attorney, Daniel Robinson of the Robinson Calcagnie law firm in Newport Beach, California. \u201cThat loyalty was a one-way street.\u2019\u2019
\nJohnson & Johnson stopped selling powder made with talc worldwide in 2023.<\/p>\n

Company Response<\/h2>\n

Erik Haas, J&J\u2019s worldwide vice president of litigation, said in a statement that the company had won \u201c16 of the 17 ovarian cancer cases it previously tried\u201d and expected to do so again upon appealing Friday\u2019s verdict.
\nHaas called the jury\u2019s findings \u201cirreconcilable with the decades of independent scientific evaluations confirming that talc is safe, does not contain asbestos, and does not cause cancer.\u2019\u2019
\nJohnson & Johnson replaced the talc in its baby powder sold in most of North America with cornstarch in 2020 after sales declined.<\/p>\n

Recent Developments<\/h2>\n

In April, a U.S. bankruptcy court judge denied J&J\u2019s plan to pay $9 billion to settle ovarian cancer and other gynecological cancer litiation claims based on talc-related products.<\/p>\n

Conclusion<\/h2>\n

The lawsuit against Johnson & Johnson is a significant development in the ongoing debate over the safety of talcum powder. While the company maintains that its products are safe, the jury’s verdict suggests that there may be a link between talc and ovarian cancer. As the case continues to unfold, it is likely that more information will come to light about the potential risks associated with talcum powder.<\/p>\n

FAQs<\/h2>\n